Fri, December 23, 2011
Thu, December 22, 2011
Wed, December 21, 2011
Tue, December 20, 2011
[ Tue, Dec 20th 2011 ] - Market Wire
Bard Acquires Lutonix, Inc.
Mon, December 19, 2011
Sun, December 18, 2011
Sat, December 17, 2011
Fri, December 16, 2011
Thu, December 15, 2011
Wed, December 14, 2011
Tue, December 13, 2011

Valeant Pharmaceuticals Completes Acquisition of Dermik


//health-fitness.news-articles.net/content/2011/ .. maceuticals-completes-acquisition-of-dermik.html
Published in Health and Fitness on Monday, December 19th 2011 at 5:07 GMT by Market Wire   Print publication without navigation


Valeant Pharmaceuticals Completes Acquisition of Dermik -- MISSISSAUGA, Ontario, Dec. 19, 2011 /PRNewswire/ --

Valeant Pharmaceuticals Completes Acquisition of Dermik

[ ]

  

 

 

 

MISSISSAUGA, Ontario, Dec. 19, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ] and TSX: VRX) announced that effective December 16, 2011, the company completed its previously announced acquisition of Dermik, a dermatology unit of Sanofi (EURONEXT: SAN and NYSE: SNY).

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at [ www.valeant.com ].

Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]

 

SOURCE Valeant Pharmaceuticals International, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.valeant.com ]


Publication Contributing Sources